Cooling cardiac arrest patients may mean better long-term brain function

(HealthDay)鈥擫owering the body temperature in patients resuscitated from cardiac arrest helps a broader group of people than previously believed, a new French study finds. For cardiac arrest patients with what’s called a “nonshockable” rhythm, cooling the body almost doubles the odds they’ll have good brain function if they survive, researchers Continue Reading

It’s not just insulin: Diabetes patients struggle to get crucial supplies

In the first three months after getting his Dexcom continuous glucose monitor, Ric Peralta said, he reduced his average blood sugar level by 3 percentage points. “It took me from not-very-well-managed blood sugar to something that was incredibly well managed,” said Peralta, a 46-year-old optician in Whittier, Calif., who was Continue Reading

Rituxan approved for pediatric patients with rare vasculitis diseases

(HealthDay)—Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older, the U.S. Food and Drug Administration announced Friday. The agency noted that pediatric patients with GPA, previously known as Continue Reading

New clinical trial analyses predict response to benralizumab by patients with COPD

Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association. More than 15.3 million people in this country suffer from it and they often experience potentially life-threatening exacerbations, which can include days-long flare-ups of symptoms including shortness of Continue Reading

One in two patients with metastatic melanoma alive after five years with combination immunotherapy

One in two patients with metastatic melanoma is alive with combination immunotherapy, according to late breaking results of the CheckMate 067 trial presented at the ESMO Congress 2019 in Barcelona, Spain. “In the past, metastatic melanoma was regarded as untreatable,” said study author Prof James Larkin, Royal Marsden NHS Foundation Continue Reading

Radiation right after surgery might not help prostate cancer patients

(HealthDay)鈥擨n the largest investigation of its kind, researchers conclude that subjecting prostate cancer patients to radiation therapy immediately after surgery doesn’t give them an advantage in staying cancer-free. The finding stems from a review of four studies that together tracked outcomes for more than 3,500 prostate cancer patients from multiple Continue Reading

Less bleeding with ticagrelor alone in high-risk patients

(HealthDay)—Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, according to a study published online Sept. 26 in the New England Journal of Medicine. The research was published to coincide with Continue Reading

Study shows nearly half of cancer patients who enter a comprehensive tobacco treatment program quit smoking

In the largest smoking cessation study of cancer patients to date, researchers from The University of Texas MD Anderson Cancer Center found that comprehensive tobacco treatment can help cancer patients successfully quit and abstain from smoking. The prospective study, published today in JAMA Network Open, analyzed 3,245 smokers treated in Continue Reading

Nearly one in three patients with lupus use prescription opioids for pain

Although there is little evidence that opioids effectively reduce pain from rheumatic diseases, a new study finds nearly one in three patients with lupus uses prescription opioids, often lasting longer than a year. Lupus, a chronic autoimmune disease, often leaves those affected with inflammation and pain throughout the body. “Rheumatic Continue Reading

Many patients not receiving first-line treatment for sinus, throat, ear infections

Investigators have now shown that only half of patients presenting with sinus, throat, or ear infections at different treatment centers received the recommended first-line antibiotics, well below the industry standard of 80 percent. The research is published this week in Antimicrobial Agents and Chemotherapy, a journal of the American Society Continue Reading

Survey suggests elderly patients with diabetes may favor more aggressive blood sugar control

Survey results of a national sample of elderly people with type 2 diabetes suggest that many long-time patients downplay medical and social factors that underpin professional recommendations for fewer medications and less aggressive treatment of high blood sugar. The survey study, conducted by Johns Hopkins Medicine researchers, concludes that many Continue Reading

Discovery of how colorectal cancer drug works will help more patients

Colorectal cancer is a common lethal disease, and treatment decisions are increasingly influenced by which genes are mutated within each patient. Some patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, although the mechanism of how this drug worked was unknown. Salk scientists have combined computational Continue Reading